Yesintek (ustekinumab )
pCPA File Number:
23030
Negotiation Status:
Concluded with an LOI
Indication(s):
for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis and ulcerative colitis
Sponsor/Manufacturer:
Biocon Biologics Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: